Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions
Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology. - Abstract - Europe PMC
Magmaris
Magmaris
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
Magmaris
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffol
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions
Magmaris
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...
Magmaris™ resorbable magnesium scaffold: state-of-art review | Future Cardiology
Magmaris
Magmaris
Magmaris
Magmaris
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
Magmaris
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Impact of strut dimensions and vessel caliber on thrombosis risk of bioresorbable scaffolds using hemodynamic metrics
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
Magmaris
Magmaris
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds - CRTonline
Magmaris
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions
Magmaris
